Careview
Established in 2017 as an SEC-registered company, the organization develops and operates molecular imaging centers in the Philippines. It operates a network of PET/CT centers (eight operational centers listed), provides PET/CT clinical imaging services using multiple radiotracers, offers patient support and financial-assistance coordination, and supports facility deployment and radiotracer supply through a partnership with a PET radiotracer manufacturer.
Industries
Nr. of Employees
small (1-50)
Careview
850 United Nations Ave., Paco, Manila, Metro Manila
Patents
Systems and methods for dynamically identifying a patient support surface and patient monitoring
US-12082922-B2
View DetailsPatient video monitoring systems and methods for thermal detection of liquids
US-12080069-B2
View DetailsPatient video monitoring systems and methods having detection algorithm recovery from changes in illumination
US-12047713-B2
View Details
Systems and methods for dynamically identifying a patient support surface and patient monitoring
US-12082922-B2
View DetailsPatient video monitoring systems and methods for thermal detection of liquids
US-12080069-B2
View DetailsPatient video monitoring systems and methods having detection algorithm recovery from changes in illumination
US-12047713-B2
View DetailsProducts
Network of PET/CT centers
An operational network of PET/CT centers across multiple cities providing imaging and related clinical services; networked operations provide redundancy during machine downtime.
Network of PET/CT centers
An operational network of PET/CT centers across multiple cities providing imaging and related clinical services; networked operations provide redundancy during machine downtime.
Services
On-site PET/CT imaging using multiple tracers for cancer detection, staging, monitoring, and for evaluation of neurodegenerative disease.
Clinical delivery of targeted radioligand therapy in conjunction with imaging for appropriate oncologic indications.
Provision and distribution of PET radiotracers to clinical centers via a partnership with a radiotracer manufacturer.
Advisory and contact support for entities interested in establishing PET/CT facilities.
On-site PET/CT imaging using multiple tracers for cancer detection, staging, monitoring, and for evaluation of neurodegenerative disease.
Clinical delivery of targeted radioligand therapy in conjunction with imaging for appropriate oncologic indications.
Provision and distribution of PET radiotracers to clinical centers via a partnership with a radiotracer manufacturer.
Advisory and contact support for entities interested in establishing PET/CT facilities.
Expertise Areas
- Molecular imaging (PET/CT)
- Theranostics and radioligand therapy
- Radiopharmaceutical logistics and supply
- Clinical imaging operations and high-throughput scanning
Key Technologies
- PET/CT imaging
- FDG PET imaging
- PSMA-targeted PET imaging
- Amyloid PET imaging
News & Updates
Company has established eight operational PET/CT centers in the Philippines.
Reported more than 22,000 patients scanned since 2015 across services.
Reported over 800 patients scanned with PSMA-targeted PET/CT since 2019.
Company has established eight operational PET/CT centers in the Philippines.
Reported more than 22,000 patients scanned since 2015 across services.
Reported over 800 patients scanned with PSMA-targeted PET/CT since 2019.